Tom J. Parry

Novel Peptide Inhibitors of Angiotensin-converting Enzyme 2

Lili Huang, Daniel J. Sexton, Kirsten Skogerson et al. · Journal of Biological Chemistry · 2003 · 222 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Albutropin: a growth hormone–albumin fusion with improved pharmacokinetics and pharmacodynamics in rats and monkeys

Blaire L. Osborn, Les Sekut, Marta L. Corcoran et al. · European Journal of Pharmacology · 2002 · 131 citations

Medicine, Pharmacokinetics, Pharmacology +8

Drug-eluting stents: Sirolimus and paclitaxel differentially affect cultured cells and injured arteries

Tom J. Parry, Ruth Brosius, Rathna Thyagarajan et al. · European Journal of Pharmacology · 2005 · 124 citations

Medicine, Cardiology, Pharmacology +13

Anti‐Remodeling and Anti‐Fibrotic Effects of the Neuregulin‐1β Glial Growth Factor 2 in a Large Animal Model of Heart Failure

Cristi L. Galindo, Ehab Kasasbeh, Abigail Murphy et al. · Journal of the American Heart Association · 2014 · 83 citations · Full text

Life Sciences, Cardiology, Physiology +13

Bioactivity of anti-angiogenic ribozymes targeting Flt-1 and KDR mRNA

Tom J. Parry, Cynthia D. Cushman, Adalberto M. Gallegos et al. · Nucleic Acids Research · 1999 · 78 citations · Full text

Medicine, Molecular Biology, Molecular Medicine +15